Related references
Note: Only part of the references are listed.WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia
Hao Luo et al.
CANCER CELL INTERNATIONAL (2019)
Role of deubiquitinases in DNA damage response
John Le et al.
DNA REPAIR (2019)
The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway
Dongyeob Seo et al.
EBIOMEDICINE (2019)
Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor
Xin Xu et al.
THERANOSTICS (2019)
The role of ubiquitin-specific peptidases in cancer progression
Ming-Jer Young et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Deubiquitylating enzymes and drug discovery: emerging opportunities
Jeanine A. Harrigan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
NCI Program for Natural Product Discovery: A Publicly-Accessible Library of Natural Product Fractions for High-Throughput Screening
Christopher C. Thornburg et al.
ACS CHEMICAL BIOLOGY (2018)
USP14 regulates DNA damage repair by targeting RNF168-dependent ubiquitination
Arishya Sharma et al.
AUTOPHAGY (2018)
Deubiquitylating enzymes as cancer stem cell therapeutics
Saba Haq et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
A Convergence-Based Framework for Cancer Drug Resistance
David J. Konieczkowski et al.
CANCER CELL (2018)
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Anaphase: a fortune-teller of genomic instability
Anna H. Bizard et al.
CURRENT OPINION IN CELL BIOLOGY (2018)
Deubiquitinating enzymes in cancer stem cells: functions and targeted inhibition for cancer therapy
Kamini Kaushal et al.
DRUG DISCOVERY TODAY (2018)
Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability
Dominika Kwasna et al.
MOLECULAR CELL (2018)
DNA Damage, Repair, and Cancer Metabolism
Marc-Olivier Turgeon et al.
FRONTIERS IN ONCOLOGY (2018)
USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and β-TrCP and promotes cancer malignancy
Yi-Chang Wang et al.
NATURE COMMUNICATIONS (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Targeting DNA damage repair in small cell lung cancer and the biomarker landscape
Triparna Sen et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis
S-A Wang et al.
ONCOGENE (2017)
Molecular basis of USP7 inhibition by selective small-molecule inhibitors
Andrew P. Turnbull et al.
NATURE (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Pathophysiological Roles of Ezrin/Radixin/Moesin Proteins
Kotoku Kawaguchi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy
Y-C Wang et al.
ONCOGENE (2016)
USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response
Zhiquan Wang et al.
GENES & DEVELOPMENT (2016)
USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation
Sathish Kumar Mungamuri et al.
CELL REPORTS (2016)
DUBs, the regulation of cell identity and disease
Johanna Heideker et al.
BIOCHEMICAL JOURNAL (2015)
Deubiquitinases (DUBs) and DUB inhibitors: a patent review
Pershang Farshi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
The Deubiquitinating Enzyme USP24 Is a Regulator of the UV Damage Response
Ling Zhang et al.
CELL REPORTS (2015)
Protoss: a holistic approach to predict tautomers and protonation states in protein-ligand complexes
Stefan Bietz et al.
JOURNAL OF CHEMINFORMATICS (2014)
Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy
K. Aziz et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Comments on the manuscript by Anckaert et al., Clin Chim Acta 2010;411:1348-53
Steven J. Soldin et al.
CLINICA CHIMICA ACTA (2011)
Ubiquitin specific proteases USP24 and USP40 and ubiquitin thiolesterase UCHL1 polymorphisms have synergic effect on the risk of Parkinson's disease among Taiwanese
Yih-Ru Wu et al.
CLINICA CHIMICA ACTA (2010)
Targeting the ubiquitin-proteasome system for cancer therapy
Yili Yang et al.
CANCER SCIENCE (2009)
DUBs and cancer The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors
Sajjad Hussain et al.
CELL CYCLE (2009)
Major SNP (Q141K) Variant of Human ABC Transporter ABCG2 Undergoes Lysosomal and Proteasomal Degradations
Tomoka Furukawa et al.
PHARMACEUTICAL RESEARCH (2009)
Regulation of DNA repair throughout the cell cycle
Dana Branzei et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease
Yonghong Li et al.
HUMAN MUTATION (2006)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
